drugset / Trial / NCT02717780

Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome

NCT02717780 ↗

Phase 4 Completed 60 enrolled Centre Hospitalier Universitaire Vaudois
RandomizedParallel-groupTriple-blindPrevention

Summary

The investigators aim to assess the respiratory effect of short half-life agents in balanced anesthesia on patients suffering from non-treated or suspected obstructive sleep apnea syndrome (OSA) We will study the impact on OSA of a regimen of remifentanil-desflurane versus a regimen of fentanyl-sevoflurane. Each patient will undergo three respiratory portable polygraphies: the night before the surgery ; the first night following the surgery ; the third night following the surgery.

Timeline

Start
2016-02
Primary completion
2018-06
Completion
2018-06

Outcome

Missed primary endpoint

paper were 20 (16-25) and 21 (16-26) events h-1 (P=0.82), respectively; corresponding values on the third postoperative night were 34 PMID 38862381 ↗

paper Use of spinal anaesthesia compared with general anaesthesia was not associated with a reduction in postoperative sleep apnoea severity PMID 38862381 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Desflurane Other / unclassified — —
Comparator Fentanyl Other / unclassified — —
Subject Remifentanil Small molecule — —
Comparator Sevoflurane Other / unclassified — —